首页 › 弥漫性内生性脑桥胶质瘤 › 伊利诺伊州 › Chicago
Chicago IL 弥漫性内生性脑桥胶质瘤临床试验
9项针对 弥漫性内生性脑桥胶质瘤的研究正在 Chicago及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
招募中1/2 期
- Lurie Children's Hospital-Chicago, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Targeted Pediatric High-Grade Glioma Therapy
招募中观察性研究
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of Olutasidenib and Temozolomide in HGG
招募中2 期
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
招募中2 期
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
招募中2 期
- Lurie Children's Hospital, Chicago
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
招募中早期 I 期欢迎健康志愿者
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Combination Therapy for the Treatment of Diffuse Midline Gliomas
招募中2 期
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
招募中2 期
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
招募中1 期
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
其他城市的 弥漫性内生性脑桥胶质瘤试验
- Washington, DC11 项研究
- Columbus, OH10 项研究
- Seattle, WA10 项研究
- Philadelphia, PA10 项研究
- Cincinnati, OH10 项研究
- Houston, TX10 项研究
- Durham, NC9 项研究
- Boston, MA9 项研究
- Aurora, CO8 项研究
- Miami, FL6 项研究
- Ann Arbor, MI6 项研究
- St. Louis, MO5 项研究
Chicago的其他研究
- 非小细胞肺癌61 项研究
- 乳腺癌59 项研究
- 癌症(所有类型)51 项研究
- 转移性癌症45 项研究
- 前列腺癌45 项研究
- 肺癌41 项研究
- 肥胖症41 项研究
- 卵巢癌36 项研究
- 结直肠癌34 项研究
- 卒中34 项研究
- 心力衰竭31 项研究
- 超重29 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。